Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Fuji Pharma Co., Ltd. (4554)
Market Closed
17 Jul, 06:00
JPX
All
(3)
DE
(2)
JP
(1)
XFRA
Primary
JPX
XDUS
¥
1,921.
00
-19
-0.9794%
¥
43.01B
Market Cap
-
P/E Ratio
0.25%
Div Yield
106,800
Volume
-
Eps
¥
1,940
Previous Close
Watching
Watch
Add Transaction
Day Range
1,888
1,940
Year Range
1,326
2,559
Want to track
4554
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Fuji Pharma Co., Ltd. (4554) Statistics
Valuation metrics
Market Cap
43.01B
Enterprise value
68.91B
Trailing P/E (ttm)
19.44
Forward P/E
15.78
PEG ratio
-0.8
Price/Sales (ttm)
0.88
Price/Book (mrq)
0.94
Enterprise Value/Revenue
1.2
Enterprise Value/EBITDA
6.2
Overview
Shares outstanding
24.46M
Float
12.28M
Shares short
-
% Held by insiders
0.46%
% Held by institutions
0.11%
Average volume (10 days)
125.92K
Average volume (90 days)
134.88K
Price summary
52-Week low
1,326
52-Week high
2,559
Beta
0.35
50-Day moving average
2,112.58
200-Day moving average
2,177.2
Dividends and splits
Forward annual dividend rate
46
Forward annual dividend yield
0.0187%
Trailing annual dividend rate
48.5
Trailing annual dividend yield
0.0252%
5-Year annual dividend yield
2.83%
Payout ratio
0.43
Dividend Date
1 Dec 2025
Ex-Dividend Date
29 Sep 2025
Last split factor
2:1
Last split Date
27 Jun 2018
Financials
Fiscal year
Fiscal year ends
30 Sep 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.04%
Operating margin
0.12%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.05%
Income Statement
Revenue (ttm)
54.57B
Revenue per share (ttm)
2,282.61
Quarterly revenue growth (yoy)
0.22%
Gross profit (ttm)
22.28B
EBITDA
9.03B
Net income to common (ttm)
2.33B
Diluted EPS (ttm)
96.65
Quarterly earnings growth (yoy)
-0.67%
Balance Sheet
Total cash (mrq)
3.39B
Total cash per share (mrq)
433.71
Total debt (mrq)
30.47B
Total Debt/Equity (mrq)
0.58
Current ratio (mrq)
1.68%
Book value per share (mrq)
2,046.29
Cash Flow
Cash flow statement
2.65B
Levered free cash flow (LFCF)
3B